36
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Association of Visual Impairment in Neuromyelitis Optica Spectrum Disorder With Visual Network Reorganization

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This cross-sectional study examines adaptive visual network connectivity changes in neuromyelitis optica spectrum disorder.

          Key Points

          Question

          Is visual impairment in neuromyelitis optica spectrum disorder associated with adaptive functional network reorganization?

          Findings

          In this cross-sectional study of 31 patients with aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder, a selective and pronounced increase of visual network functional connectivity was observed. This increased connectivity was associated with impaired visual function and retinal damage and was more pronounced in patients with a history of optic neuritis.

          Meaning

          Visual impairment and anterior visual system damage are associated with a selective reorganization of functional visual networks in neuromyelitis optica spectrum disorder.

          Abstract

          Importance

          Severe visual impairment is one of the major symptoms in neuromyelitis optica spectrum disorder (NMOSD), but functional network reorganization induced by the diminished sensory input has not been investigated thus far.

          Objective

          To examine adaptive visual network connectivity changes in NMOSD.

          Design, Setting, and Participants

          In this cross-sectional study, data were collected from May 1, 2013, through February 31, 2016, from 31 patients with aquaporin-4 antibody–positive NMOSD and 31 age- and sex-matched healthy control individuals at the

          Department of Neurology and NeuroCure Clinical Research Center at Charité–Universitätsmedizin Berlin, Berlin, Germany.

          Main Outcomes and Measures

          Visual function (high-contrast visual acuity and contrast sensitivity), optical coherence tomography (peripapillary retinal nerve fiber layer and ganglion cell layer thickness), and resting-state functional magnetic resonance imaging (functional connectivity of large-scale brain networks).

          Results

          Thirty-one patients with NMOSD (mean [SD] age, 48.2 [13.9] years; 28 women and 3 men) and 31 healthy controls (mean [SD] age, 47.2 [15.3] years; 28 women and 3 men) participated in the study. Patients had a selective and pronounced increase of functional connectivity in the primary and secondary visual networks. Increased primary visual network connectivity correlated with reduced high-contrast visual acuity ( r = −0.39, P = .006), reduced low-contrast sensitivity ( r = −0.33, P = .03), and more severe retinal damage measured by optical coherence tomography ( r = −0.4, P = .01). Furthermore, visual functional connectivity was significantly higher in patients with a history of optic neuritis compared with patients without optic neuritis (mean [SD] regression coefficients, 50.0 [4.3] vs 34.6 [5.6]; P = .04).

          Conclusions and Relevance

          Impaired visual function and retinal damage are associated with selective reorganization of the visual network in NMOSD. These findings advance the understanding of visual system dysfunction in NMOSD and, more generally, provide insight into pathophysiologic responses of the visual system to impaired visual input.

          Related collections

          Author and article information

          Journal
          JAMA Neurol
          JAMA Neurol
          JAMA Neurol
          JAMA Neurology
          American Medical Association
          2168-6149
          2168-6157
          2 January 2018
          March 2018
          2 January 2019
          : 75
          : 3
          : 296-303
          Affiliations
          [1 ]Department of Neurology, Charité–Universitätsmedizin Berlin, Berlin, Germany
          [2 ]Berlin School of Mind and Brain, Humboldt-Universität zu Berlin, Berlin, Germany
          [3 ]NeuroCure Clinical Research Center, Charité–Universitätsmedizin Berlin, Berlin, Germany
          [4 ]Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité–Universitätsmedizin Berlin, Berlin, Germany
          Author notes
          Article Information
          Corresponding Author: Carsten Finke, MD, Department of Neurology, Charité–Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany ( carsten.finke@ 123456charite.de ).
          Accepted for Publication: June 26, 2017.
          Published Online: January 2, 2018. doi:10.1001/jamaneurol.2017.3890
          Author Contributions: Dr Finke had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
          Study concept and design: Finke, Paul.
          Acquisition, analysis, or interpretation of data: All authors.
          Drafting of the manuscript: Finke, Paul.
          Critical revision of the manuscript for important intellectual content: All authors.
          Statistical analysis: Finke, Zimmermann.
          Obtained funding: Ruprecht, Brandt, Paul.
          Administrative, technical, or material support: Finke, Pache, Bellmann-Strobl, Paul.
          Study supervision: Finke, Ruprecht, Brandt, Paul.
          Conflict of Interest Disclosures: None reported.
          Funding/Support: This work was supported by grant Exc 257 from the German Research Foundation, the Bundesministerium für Bildung und Forschung (Competence Network Multiple Sclerosis), and Guthy Jackson Charitable Foundation (Dr Paul).
          Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
          Article
          PMC5885866 PMC5885866 5885866 noi170094
          10.1001/jamaneurol.2017.3890
          5885866
          29297041
          ffd02903-a9d0-47be-a6a0-1b94b83f43cb
          Copyright 2018 American Medical Association. All Rights Reserved.
          History
          : 16 January 2017
          : 26 April 2017
          : 26 June 2017
          Categories
          Research
          Research
          Original Investigation
          Online First

          Comments

          Comment on this article